Abstract P1-19-42: Evaluation of mean corpuscular volume (MCV) as a pharmacodynamic predictive biomarker in patients receiving CDK4/6 inhibitors for metastatic breast cancer (MBC) by Choong, Grace Mei Yee, Leon-Ferre, Roberto A, O'Sullivan, Ciara C, Ruddy, Kathyrn J, Haddad, Tufia C, Hobday, Timothy J, Peethambaram, Prema P, Loprinizi, Charles L, Liu, Minetta C, Suman, Vera J, Goetz, Matthew P, Giridhar, Karthik V

Get full text